Abstract
Westlake Chemical will release first-quarter 2026 results on May 5, 2026 Pre-Market, with investors watching management’s delivery versus revenue near 2.76 billion US dollars and adjusted EPS around -0.23 as pricing, volumes, and input costs set the path for margin normalization.
Market Forecast
For the current quarter, Westlake Chemical’s forecast embedded in recent disclosures points to revenue of 2.76 billion US dollars, a 6.47% decrease year over year, and adjusted EPS of -0.23, implying a 135.32% year-over-year decline; EBIT is guided around 6.11 million US dollars, down 95.53% year over year. Guidance for gross profit margin and net margin was not provided in the dataset.
The main business remains anchored by two reporting lines: Performance and Essential Materials and Housing and Infrastructure Products, with a near-term outlook tied to pricing, seasonal demand, and execution on cost controls. The most promising segment for upside this quarter is Performance and Essential Materials, which generated 1.63 billion US dollars last quarter; year-over-year growth by segment was not disclosed in the dataset.
Last Quarter Review
In the previous quarter, Westlake Chemical posted revenue of 2.53 billion US dollars (-10.90% year over year), a gross profit margin of 3.43%, a GAAP net loss attributable to shareholders of 544.00 million US dollars with a net margin of -21.48%, and adjusted EPS of -0.29 (down 583.33% year over year).
A notable financial highlight was sequential improvement in GAAP net income, with net profit trending 30.43% higher quarter over quarter even as margins remained compressed. By business line, Performance and Essential Materials contributed 1.63 billion US dollars while Housing and Infrastructure Products delivered 901.00 million US dollars; year-over-year growth by segment was not disclosed, but mix effects and pricing were key drivers.
Current Quarter Outlook
Main business dynamics this quarter
The quarter-to-date setup is defined by stabilization in selling prices across key product groups and an improving volume backdrop as end-market activity normalizes from a soft fourth quarter. Revenue in the recent quarter was 2.53 billion US dollars, and the company’s own forecast centers near 2.76 billion US dollars for the current period, consistent with a modest sequential step-up but a 6.47% decline year over year. The company’s adjusted EPS was -0.29 last quarter and is guided to roughly -0.23, underscoring a near-term earnings trough as pricing lags input costs and production schedules.
Gross margin was 3.43% last quarter and net margin -21.48%, reflecting unfavorable spread conditions and the tail impact of past price resets. The key debate for this quarter is how much incremental price and mix can offset fixed-cost absorption and any residual inflation in logistics and utilities. Even a small improvement in realized prices on higher throughput can translate into outsized earnings delta because unit margins were compressed to low single digits last quarter.
Execution on operating discipline is central. The last quarter’s sequential improvement in GAAP net income (+30.43% quarter over quarter) offers a base for further normalization if volumes lift and conversion costs ease. The EBIT framework suggests a low starting point (6.11 million US dollars estimate for the current quarter, down 95.53% year over year), so modest positive variances in pricing, volumes, or energy costs could produce meaningful upside against low expectations.
Most promising segment this quarter
Performance and Essential Materials stands out for incremental upside potential. It contributed 1.63 billion US dollars last quarter and typically benefits the most when spreads start to stabilize and operating rates improve, given its higher sensitivity to price and volume changes. With the company’s distribution reach for epoxy products expanded in select geographies during the first quarter period, this portfolio is positioned to capture incremental orders as coatings, adhesives, and construction applications pick up.
Commercial execution in EPIKOTE/EPI-REZ and related epoxy systems, coupled with better network utilization, could underpin a sequential lift. While year-over-year segment growth data are not available in the current dataset, the near-term setup favors a sequential revenue recovery supported by seasonal demand and product availability. The magnitude of improvement will hinge on the breadth of restocking orders and realized pricing in contract renewals and spot markets; even small upticks should drop through at high incremental margins given the low gross profit starting point last quarter.
Operationally, tighter coordination between sales, production planning, and logistics can reduce working capital frictions and improve fulfillment timing in this segment. If realized, the combination of slightly higher prices, steadier volumes, and mix gains toward higher-value formulations would support EBIT outperformance versus the low baseline embedded in current-quarter expectations.
Key swing factors for the share price this quarter
Margin cadence is the primary swing factor. With gross margin at 3.43% in the last quarter, even a modest improvement in spreads can move the earnings needle significantly, which is why the stock’s reaction will likely hinge on management’s commentary around intra-quarter price trends, order books, and conversion costs. The EBIT outlook (6.11 million US dollars estimate, down 95.53% year over year) also sets a low bar that could amplify the impact of incremental positive surprises.
Cost visibility and throughput consistency are the second swing factor. The sequential net income improvement last quarter points to better operating rhythm, but the sustainability of that trend depends on plant reliability, maintenance schedules, and any short-cycle supply chain disruptions. Investors will listen for updates on unit cost reductions, procurement savings, and freight normalization, since these can reinforce the path from a negative net margin (-21.48% last quarter) toward breakeven.
Finally, capital allocation signals could affect sentiment. The company maintained its quarterly dividend earlier this year, and reiteration of balanced priorities around maintenance capex, working capital discipline, and shareholder returns would support confidence in cash flow normalization. If management pairs steady capital return with evidence of better pricing and order momentum, the stock could respond favorably even if reported results are modestly below year-ago levels.
Analyst Opinions
The balance of published views in the year-to-date window is skewed bullish, with a roughly 5-to-1 ratio of positive to negative stances among major brokers and research outfits. On the bullish side, several institutions have reiterated positive ratings while lifting or reaffirming price targets, emphasizing a view that earnings are near a cyclical low and that margin recovery is plausible as pricing steadies and costs normalize.
RBC Capital maintains an Outperform view and recently raised its price target to 145 US dollars, underscoring the thesis that operating leverage can reemerge as spreads stabilize and volumes firm through the midyear period. Their stance highlights the potential for better realized prices in key lines and for incremental cost takeout to accelerate the rebound from last quarter’s depressed 3.43% gross margin. They also frame the near-term revenue outlook around a sequential pickup consistent with the company’s 2.76 billion US dollars forecast for the current quarter.
UBS stays constructive, lifting its target to 139 US dollars while keeping a Buy recommendation. The bank’s positive case centers on trough earnings dynamics and the inherent sensitivity of results to small improvements in price and throughput; this is particularly relevant with EBIT expected at just 6.11 million US dollars in the current quarter, a base that could be beaten if pricing and volume trends are fractionally better than assumed. UBS also notes that disciplined capital deployment and stable dividends help underpin the equity story while the earnings bridge rebuilds.
Citi continues with a Buy rating and a 130 US dollars target, pointing to catalysts in the second and third quarters as contract resets capture firmer pricing and as seasonal demand supports order patterns across building products and epoxy applications. From Citi’s vantage point, the setup is asymmetrically favorable: the last quarter’s adjusted EPS was -0.29 and the current quarter’s expectation is -0.23, so incremental improvements in margin or mix could produce a visibly better earnings trajectory into the back half of the year.
Alembic Global also reiterates a Buy stance with a target of 100 US dollars, aligning with the broader view that the prior quarter marked a stress point for profitability and that the next leg hinges on execution and price follow-through. Their bullish framing reflects confidence in commercial initiatives and geographic channel expansion, including the broader distribution coverage for epoxy systems, which can accelerate mix enrichment.
In aggregate, the bullish camp focuses on four pillars: a low earnings base that enhances operating leverage to even modest pricing and volume gains; preliminary signs of sequential improvement (including the 30.43% quarter-on-quarter improvement in GAAP net income last quarter); commercial progress in higher-value formulations and broader distribution reach; and consistent capital allocation that maintains shareholder returns. This cohort expects management’s commentary on May 5, 2026 to validate a sequential revenue step-up to about 2.76 billion US dollars and to outline incremental actions that make the path from a -21.48% net margin toward stabilization credible over the next few quarters.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments